Violation Tracker Individual Record
Company:
AstraZeneca
Current Parent Company:
AstraZeneca
Penalty:
$198,000,000
Year:
2010
Date:
August 10, 2010
Offense Group:
safety-related offenses
Primary Offense:
drug or medical equipment safety violation
Secondary Offense:
product safety violation
Violation Description:
AstraZeneca agreed to pay $198 million to settle multi-district litigation alleging that its anti-psychotic drug Seroquel created an elevated risk for diabetes.
Level of Government:
federal
Action Type:
private litigation
Court:
Middle District of Florida
Civil or Criminal Case:
civil
Case ID:
6:06md1769
Case Name:
In Re: Seroquel Products Liability Litigation
Private Lawsuit Resolution Type:
settlement
HQ Country of Parent:
United Kingdom
Ownership Structure of Parent:
publicly traded
Major Industry of Parent:
pharmaceuticals
Specific Industry of Parent:
pharmaceuticals
Source of Data:
https://www.law360.com/articles/186391/astrazeneca-to-pay-198m-to-end-seroquel-suits
Link to PACER Case Docket (must be logged in):
https://ecf.flmd.uscourts.gov/cgi-bin/DktRpt.pl?184218
Source Notes:
If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Parent company note:
Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.
